Development of Mirror-Image VHHs with Less Immunogenicity
This book outlines the chemical synthesis of therapeutic targets and a screening process for unexplored mirror-image single-domain antibodies (D-VHH). This book first describes the chemical synthesis of model VHH and the characteristics of both enantiomeric VHHs, including binding activity, biodistr...
保存先:
| 第一著者: | |
|---|---|
| 団体著者: | |
| フォーマット: | 電子媒体 eBook |
| 言語: | 英語 |
| 出版事項: |
Singapore :
Springer Nature Singapore : Imprint: Springer,
2025.
|
| 版: | 1st ed. 2025. |
| シリーズ: | Springer Theses, Recognizing Outstanding Ph.D. Research,
|
| 主題: | |
| オンライン・アクセス: | https://doi.org/10.1007/978-981-96-1301-4 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|
MARC
| LEADER | 00000nam a22000005i 4500 | ||
|---|---|---|---|
| 001 | 978-981-96-1301-4 | ||
| 003 | DE-He213 | ||
| 005 | 20260706120913.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 250114s2025 si | s |||| 0|eng d | ||
| 020 | |a 9789819613014 |9 978-981-96-1301-4 | ||
| 024 | 7 | |a 10.1007/978-981-96-1301-4 |2 doi | |
| 050 | 4 | |a QD1-999 | |
| 072 | 7 | |a PN |2 bicssc | |
| 072 | 7 | |a SCI013000 |2 bisacsh | |
| 072 | 7 | |a PN |2 thema | |
| 082 | 0 | 4 | |a 541.39 |2 23 |
| 100 | 1 | |a Aoki, Keisuke. |e author. |4 aut |4 http://id.loc.gov/vocabulary/relators/aut | |
| 245 | 1 | 0 | |a Development of Mirror-Image VHHs with Less Immunogenicity |h [electronic resource] / |c by Keisuke Aoki. |
| 250 | |a 1st ed. 2025. | ||
| 264 | 1 | |a Singapore : |b Springer Nature Singapore : |b Imprint: Springer, |c 2025. | |
| 300 | |a XI, 116 p. 56 illus., 36 illus. in color. |b online resource. | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 341 | 0 | |b Table of contents navigation |2 onix | |
| 341 | 0 | |b Single logical reading order |2 onix | |
| 341 | 0 | |b Short alternative textual descriptions |2 onix | |
| 341 | 0 | |b Use of color is not sole means of conveying information |2 onix | |
| 341 | 0 | |b Use of high contrast between text and background color |2 onix | |
| 341 | 0 | |b Next / Previous structural navigation |2 onix | |
| 341 | 0 | |b All non-decorative content supports reading without sight |2 onix | |
| 347 | |a text file |b PDF |2 rda | ||
| 490 | 1 | |a Springer Theses, Recognizing Outstanding Ph.D. Research, |x 2190-5061 | |
| 505 | 0 | |a Chapter 1.Introduction -- Chapter 2.Chemical Synthesis of Mirror-Image VHHs and Evaluation of Their Immunogenicity -- Chapter 3.Identification of a Mirror-Image VHH against Vascular Endothelial Growth Factor -- Chapter 4.Synthetic Study of Full-Length Hepatitis B Virus Core Protein and Its Capsid Assembly -- Chapter 5.Chemical Synthesis of Interleukin-6 for Mirror-Image VHH Discovery -- Chapter 6.Conclusions. | |
| 520 | |a This book outlines the chemical synthesis of therapeutic targets and a screening process for unexplored mirror-image single-domain antibodies (D-VHH). This book first describes the chemical synthesis of model VHH and the characteristics of both enantiomeric VHHs, including binding activity, biodistribution and immunogenicity. Immunogenicity testing in mice demonstrated that administration of conventional L-VHH induced the generation of anti-drug antibodies while D-VHH-binding antibodies were not observed in D-VHH-immunized mice. Second, it is explained that the T7-phage-based mirror-image screening system was developed to identify D-VHH antibody fragments capable of binding to vascular endothelial growth factors. Additionally, this book details the chemical synthesis of full-length hepatitis B virus core protein and interleukin-6 for the application of exploring D-VHHs and other mirror-image molecules. Demonstrating that it is possible to develop a D-VHH that preferentially binds the native target protein and exhibits reduced immunogenicity, this book is useful for anyone interested in developing alternative biotherapeutics with reduced immunogenicity by combining chemical and biological approaches. | ||
| 532 | 8 | |a Accessibility summary: This PDF does not fully comply with PDF/UA standards, but does feature limited screen reader support, described non-text content (images, graphs), bookmarks for easy navigation and searchable, selectable text. Users of assistive technologies may experience difficulty navigating or interpreting content in this document. We recognize the importance of accessibility, and we welcome queries about accessibility for any of our products. If you have a question or an access need, please get in touch with us at accessibilitysupport@springernature.com. | |
| 532 | 8 | |a No reading system accessibility options actively disabled | |
| 532 | 8 | |a Publisher contact for further accessibility information: accessibilitysupport@springernature.com | |
| 650 | 0 | |a Chemistry. | |
| 650 | 0 | |a Pharmacy. | |
| 650 | 0 | |a Proteins. | |
| 650 | 0 | |a Immunogenetics. | |
| 650 | 1 | 4 | |a Chemical Synthesis. |
| 650 | 2 | 4 | |a Pharmacy. |
| 650 | 2 | 4 | |a Proteins. |
| 650 | 2 | 4 | |a Immunogenetics. |
| 710 | 2 | |a SpringerLink (Online service) | |
| 773 | 0 | |t Springer Nature eBook | |
| 776 | 0 | 8 | |i Printed edition: |z 9789819613007 |
| 776 | 0 | 8 | |i Printed edition: |z 9789819613021 |
| 776 | 0 | 8 | |i Printed edition: |z 9789819613038 |
| 830 | 0 | |a Springer Theses, Recognizing Outstanding Ph.D. Research, |x 2190-5061 | |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-981-96-1301-4 |
| 912 | |a ZDB-2-CMS | ||
| 912 | |a ZDB-2-SXC | ||
| 912 | |a ZDB-2-249 | ||
| 950 | |a Chemistry and Materials Science (SpringerNature-11644) | ||
| 950 | |a Chemistry and Material Science (R0) (SpringerNature-43709) | ||
| 950 | |a Focus Bundle Chemistry and Materials Science (SpringerNature-85419) | ||